GE HealthCare (GEHC)
NASDAQHealth CareMedical - DevicesSnapshot 2026-11-05
NASDAQHealth CareMedical - DevicesSnapshot 2026-11-05
QuarterlyIQ Insights · GEHC
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance is holding in the top half of its industry — the reason to own it looks intact.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | 7.1% |
| Our one-year growth estimate | diamond | 5.2% |
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
Usually moved in the opposite direction.
Price observations: 365 days
Usually moved in the same direction.
Price observations: 365 days
Most sensitive to the US dollar and the broad stock market.
Based on historical daily prices through 2026-11-05.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
A larger daily loss that occurred about once in every 20 trading days.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Growth built into the price is above our model estimate.
The price assumes 1.9 percentage points more one-year growth.
The one-year revenue growth assumption on Valuation.
Model as of 2026-11-05 · Compared with 42 industry peers · Company calendar date is not available
GEHC — CEO transition
Dated 2026-10-28
President and CEO, Patient Care Solutions — Jeannette Bankes: The resignation of a President and CEO of a major business segment represents a significant loss of senior leadership.
Why it matters: Management raised its 2026 growth view after Q3 growth reached 6.2%. The next report will show if that pace holds.
Supportive ifFull-year 2026 organic revenue growth is about 4.0%, matching the updated guide.
Worry ifFull-year organic revenue growth lands below 3.0%, under the old guide range.
Why it matters: The $945 million deal would add U.S. PET drug supply sites. Approval and closing would mark a clear step in this expansion.
Supportive ifGE HealthCare reports that regulators approved the deal and that it closed by the end of June 2027.
Worry ifThe deal is not closed by June 30, 2027, or the company reports that it was blocked or ended.
Why it matters: Q3 free cash flow was $793 million, including a $55 million tariff refund. The year-end result will test the raised cash goal.
Supportive ifFull-year 2026 free cash flow is at least $1.6 billion.
Worry ifFull-year free cash flow is below the prior guide of about $1.6 billion.
Why it matters: Q3 margin rose to 16.6%, and the full-year guide is 15.5% to 15.7%. A result in that range would show margin gains held.
Supportive ifFull-year 2026 adjusted EBIT margin is at least 15.5%, within the updated 15.5% to 15.7% guide.
Worry ifFull-year adjusted EBIT margin is below 15.4%, under the prior guide range.
We watch for confirming and disproving signals on each item. Resolutions are found automatically where possible and checked by hand for unclear cases. Last 90 days shown.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$107 on $10,000 · ±1.1% | How much price usually moves either way. |
| Bad day | $317 loss on $10,000 · 3.2% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $3,247 loss on $10,000 · 32.5% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.